Show simple item record

dc.contributor.authorLiu, B
dc.contributor.authorMosienko, V
dc.contributor.authorVaccari Cardoso, B
dc.contributor.authorProkudina, D
dc.contributor.authorHuentelman, MJ
dc.contributor.authorTeschemacher, AG
dc.contributor.authorKasparov, S
dc.date.accessioned2019-01-30T13:52:47Z
dc.date.issued2018-09-27
dc.description.abstractDiscovery of neuroprotective pathways is one of the major priorities for neuroscience. Astrocytes are the natural neuroprotectors and it is likely that brain resilience can be enhanced by mobilising their protective potential. Among G-protein coupled receptors expressed by astrocytes, two highly related receptors, GPR37L1 and GPR37, are of particular interest. Previous studies suggested that these receptors are activated by a peptide Saposin C and its neuroactive fragments (such as prosaptide TX14), which were demonstrated to be neuroprotective in various animal models by several groups. However, pairing of Saposin C or prosaptides with GPR37L1/GPR37 has been challenged and presently GPR37L1/GPR37 have regained their orphan status. Here we demonstrate that in their natural habitat, astrocytes, these receptors mediate a range of effects of TX14, including protection from oxidative stress. The Saposin C/GPR37L1/GPR37 pathway is also involved in the neuroprotective effect of astrocytes on neurons subjected to oxidative stress. The action of TX14 is at least partially mediated by Gi-proteins and the cAMP-PKA axis. On the other hand, when recombinant GPR37L1 or GPR37 are expressed in HEK293 cells, they are not functional and do not respond to TX14, which explains unsuccessful attempts to confirm the ligand-receptor pairing. Therefore this study identifies GPR37L1/GPR37 as the receptors for TX14, and, by extension of Saposin C, and paves the way for the development of neuroprotective therapeutics acting via these receptors.en_GB
dc.description.sponsorshipBiotechnology and Biological Sciences Research Councilen_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.identifier.citationVol. 66 (110, pp. 414-2426en_GB
dc.identifier.doi10.1002/glia.23480
dc.identifier.grantnumberBB/L019396/1en_GB
dc.identifier.grantnumberMR/L020661/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/35655
dc.language.isoenen_GB
dc.publisherWileyen_GB
dc.rights© 2018 The Authors. GLIA Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectNeuroprotectionen_GB
dc.subjectAstroprotectionen_GB
dc.subjectorphan receptoren_GB
dc.subjectGPR37L1en_GB
dc.subjectGPR37en_GB
dc.subjectSaposin Cen_GB
dc.subjectprosaptideen_GB
dc.subjectastrocyteen_GB
dc.subjectPKAen_GB
dc.subjectcAMPen_GB
dc.titleGlio- and neuroprotection by prosaposin is mediated by orphan G-protein coupled receptors GPR37L1 and GPR37en_GB
dc.typeArticleen_GB
dc.date.available2019-01-30T13:52:47Z
dc.identifier.issn0894-1491
dc.descriptionThis is the author accepted manuscript. Available on open access from Wiley via the DOI in this recorden_GB
dc.identifier.journalGliaen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2018-06-04
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2018-06-04
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-01-30T13:50:12Z
refterms.versionFCDAM
refterms.dateFOA2019-01-30T13:52:49Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. GLIA Published by Wiley Periodicals, Inc.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2018 The Authors. GLIA Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.